Our Start-up of the Week is CroíValve, a spin-out from the Trinity Centre for Bioengineering that has developed a minimally invasive treatment for heart failure. “CroíValve is developing a solution to ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), was awarded funding from Horizon ...

The funding will finance an early feasibility study of its flagship product Duo to evaluate its safety and performance in treating tricuspid regurgitation. CroíValve, a medtech start-up that spun out ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, announced today the ...

CroíValve, a medtech company focused on solutions for tricuspid regurgitation (TR), has announced the initiation of its Early Feasibility Study (EFS) for the DUO Tricuspid Coaptation Valve System, ...

Dublin-based medtech start-up CroíValve has today announced the closing of $16m in Series B financing. The new funding round was led by the MedTech & Irrus Syndicates and included participation from ...

Croívalve, a Dublin-based startup supported by Enterprise Ireland that is developing a treatment for tricuspid regurgitation (TR), recently secured €4 million (US$4.4 million) in additional financing.

Early-stage medical devices company CroíValve has raised €3.2 million oversubscribed seed financing round. The company, which has developed a minimally invasive device to treat defective heart valves, ...

Dublin-based medtech start-up CroíValve has raised €8m in a Series A Round of funding for a feasibility clinical study of its DUO Coaptation valve system. CroíValve, a spinout from the Trinity Centre ...

€4 million in additional financing has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterprise Ireland developing a treatment for tricuspid regurgitation (TR). This is an ...

CroíValve, an Irish medtech company that has developed a minimally invasive device to treat defective heart valves, has raised €8 million in funding. The company, which was spun-out of Trinity College ...